CSIMarket
 


Dendreon Corp  (DNDN)
Other Ticker:  
 
 

DNDN's Net Income Growth by Quarter and Year

Dendreon's Net Income results by quarter and year




DNDN Net Income (in millions $) FY 2014 FY 2013 FY 2012 FY 2011
IV Quarter December - -88.74 -38.70 0.00
III Quarter September -22.07 -67.22 -154.86 0.00
II Quarter June -15.27 -68.84 -96.14 0.00
I Quarter March -36.38 -72.01 -103.91 0.00
FY   -73.72 -296.81 -393.61 0.00



DNDN Net Income third quarter 2014 Y/Y Growth Comment
Dendreon Corp in the third quarter 2014 recorded net loss of $ -22.07 millions.

According to the results reported in the third quarter 2014, Dendreon Corp achieved the best Net Income growth in Biotechnology & Pharmaceuticals industry. While Dendreon Corp' s Net Income no change of % ranks overall at the positon no. in the third quarter 2014.




DNDN Net Income ( Y/Y Growth %) 2014
2013 2012 2011
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Dendreon's third quarter 2014 Net Income $ -22.07 millions DNDN's Income Statement
Dendreon's third quarter 2013 Net Income $ -67.22 millions Quarterly DNDN's Income Statement
New: More DNDN's historic Net Income Growth >>


DNDN Net Income (Quarter on Quarter Growth %)

2014
2013 2012 2011
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2014 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2014 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2011, 2012, 2013, 2014

Dendreon's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


DNDN's III. Quarter Q/Q Net Income Comment
Recent accomplishment of -22.07 millions by Dendreon Corp come out even more unfavourable considering the -15.27 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Dendreon Corp achieved highest sequential Net Income growth. While Dendreon's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


DNDN's III. Quarter Q/Q Net Income Comment
III. Quarter 2014 net loss of -22.07 millions by Dendreon Corp come out even less good compare to the -15.27 millions net loss in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Dendreon Corp achieved highest sequential Net Income growth. While Dendreon's Net Income growth quarter on quarter, overall rank is .


Dendreon's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2014)
12 Months Ending
(Jun 30 2014)
12 Months Ending
(Mar 31 2014)
12 Months Ending
(Dec 31 2013)
12 Months Ending
(Sep 30 2013)
Cumulative Net Income 12 Months Ending $ -162.46 $ -207.61 $ -261.18 $ -296.80 $ -246.76
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment


Dendreon Corp achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment


Dendreon Corp achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Pharmaceuticals Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
DNDN's Net Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for DNDN's Competitors
Net Income Growth for Dendreon's Suppliers
Net Income Growth for DNDN's Customers

You may also want to know
DNDN's Annual Growth Rates DNDN's Profitability Ratios DNDN's Asset Turnover Ratio DNDN's Dividend Growth
DNDN's Roe DNDN's Valuation Ratios DNDN's Financial Strength Ratios DNDN's Dividend Payout Ratio
DNDN's Roa DNDN's Inventory Turnover Ratio DNDN's Growth Rates DNDN's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2014 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2014
Insys Therapeutics, Inc.-0.71%$ -0.708 millions
Assertio Holdings inc -0.92%$ -0.921 millions
Ipc Healthcare, Inc.-5.03%$ -5.031 millions
Dentsply Sirona Inc -5.74%$ -5.742 millions
Laboratory Corporation Of America Holdings-7.48%$ -7.485 millions
Iridex Corp-7.55%$ -7.547 millions
St Jude Medical Inc-7.94%$ -7.937 millions
Amgen Inc -9.06%$ -9.064 millions
China Yct International Group, Inc.-9.15%$ -9.147 millions
Varian Medical Systems Inc -9.75%$ -9.754 millions
Encompass Health Corporation-10.37%$ -10.373 millions
Lifeloc Technologies Inc -10.57%$ -10.570 millions
Bio techne Corp-12.84%$ -12.837 millions
Psychemedics Corp-12.84%$ -12.842 millions
Baxter International Inc -13.97%$ -13.971 millions
Intuitive Surgical Inc -21.11%$ -21.110 millions
Ensign Group Inc-21.12%$ -21.118 millions
Universal Health Services Inc -21.98%$ -21.983 millions
Merck and Co Inc -26.78%$ -26.783 millions
Ufp Technologies Inc -28.43%$ -28.427 millions
Yunhong Green Cti Ltd -29.59%$ -29.586 millions
National Healthcare Corp-35.46%$ -35.458 millions
Surmodics Inc-36.41%$ -36.408 millions
Icu Medical Inc-41.74%$ -41.744 millions
Reliv International Inc-43.30%$ -43.300 millions
Regeneron Pharmaceuticals Inc -43.58%$ -43.583 millions
Abbott Laboratories-44.31%$ -44.306 millions
Stryker Corp-44.66%$ -44.660 millions
Magellan Health inc -45.42%$ -45.423 millions
Abbvie inc -47.51%$ -47.510 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com